Galderma has launched Alastin across Japan and key Asia-Pacific markets, marking a significant regional footprint expansion for the Swiss skincare brand. The move capitalizes on rising aesthetic procedure volume in the region, where GLP-1 adoption and preventive anti-aging trends are driving patient demand.
Business & M&A
Galderma Launches Alastin in Japan, Asia-Pacific Markets
Skincare brand enters region as aesthetics demand accelerates across Asia.
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Galderma expands skincare footprint into Japan and Asia-Pacific as regional aesthetic demand accelerates.
Alastin's entry into Asia-Pacific complements Galderma's core injectables portfolio (Botox, Juvéderm) and positions the company to capture the full patient journey—from pre-procedure prep through post-treatment recovery. The brand's restorative peptide and enzyme-based formulations appeal to practices seeking high-margin skincare add-ons alongside toxin and filler revenue. For practice owners, this signals Galderma's strategy to deepen wallet share in high-growth markets where aesthetic spending is accelerating.
Source: original report ↗
Frequently asked questions
Is Alastin available in Japan now?
Yes, Galderma has officially launched Alastin across Japan and key Asia-Pacific markets. The launch capitalizes on rising aesthetic procedure volume and GLP-1 adoption trends driving patient demand in the region.
What is Alastin skincare used for in med spas?
Alastin specializes in restorative peptide and enzyme-based formulations designed for pre-procedure prep and post-treatment recovery. Practices use it as a high-margin skincare add-on alongside injectables like Botox and Juvéderm to capture additional revenue from patients.
Why is Galderma expanding Alastin to Asia-Pacific?
Galderma is expanding into Asia-Pacific to capitalize on accelerating aesthetic spending, rising procedure volumes, and preventive anti-aging trends driven by GLP-1 adoption. The move allows the company to deepen wallet share by offering the full patient journey from pre-care through post-treatment recovery.
Can I bundle Alastin with Botox and Juvéderm at my practice?
Yes, Alastin's launch complements Galderma's core injectables portfolio and is specifically positioned to work alongside Botox and Juvéderm. This bundling strategy helps practices maximize patient lifetime value and margin by offering comprehensive pre- and post-procedure skincare solutions.
What markets in Asia-Pacific are getting Alastin?
Galderma has launched Alastin across Japan and key Asia-Pacific markets, though specific country-by-country rollout details were not disclosed. The expansion targets high-growth aesthetic markets where procedure demand and preventive anti-aging spending are accelerating.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.